Literature DB >> 9032332

Distinct domains of adenovirus E1A interact with specific cellular factors to differentially modulate human immunodeficiency virus transcription.

S F Parker1, L K Felzien, N D Perkins, M J Imperiale, G J Nabel.   

Abstract

Transcription of human immunodeficiency virus (HIV) type 1 and other viruses is regulated by the transcription factor NF-kappaB, which interacts with the multifunctional cellular protein p300. p300, originally identified by its ability to bind adenovirus early region 1A (E1A), has also been shown to regulate HIV transcription through its interaction with NF-kappaB. The 13S form of E1A activates HIV gene expression, while the 12S form represses its transcription. In this report, we have investigated whether these divergent effects of E1A are dependent upon common or distinct cellular cofactors, including p300, pRb, and the TATA box-binding protein (TBP). Unlike activation in the absence of E1A, cooperative stimulation of HIV gene expression by 13S E1A and RelA was independent of the ability of E1A to bind p300 but was critically dependent on the E1A CR3 region which associates with TBP. In contrast, inhibition of basal HIV gene expression by the 12S form of E1A was dependent on p300 but not pRb or TBP. Interestingly, mutation of the CR2 region of 12S E1A responsible for pRb binding abolished the repression of HIV transcription stimulated by tumor necrosis factor alpha, suggesting that repression of cytokine-activated transcription involves cofactors different from those used in unstimulated cells. Repression and activation of HIV transcription by different forms of E1A are mediated by distinct sets of cellular cofactors. These findings suggest that E1A has evolved to interact by alternative mechanisms with a transcriptional coactivator and its associated cofactors to differentially modulate cellular and viral gene expression.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9032332      PMCID: PMC191285     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

1.  Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor.

Authors:  R Eckner; M E Ewen; D Newsome; M Gerdes; J A DeCaprio; J B Lawrence; D M Livingston
Journal:  Genes Dev       Date:  1994-04-15       Impact factor: 11.361

2.  Complex splicing patterns of RNAs from the early regions of adenovirus-2.

Authors:  L T Chow; T R Broker; J B Lewis
Journal:  J Mol Biol       Date:  1979-10-25       Impact factor: 5.469

Review 3.  Transcriptional modulation by the adenovirus E1A gene.

Authors:  N Jones
Journal:  Curr Top Microbiol Immunol       Date:  1995       Impact factor: 4.291

4.  Repression in vitro, by human adenovirus E1A protein domains, of basal or Tat-activated transcription of the human immunodeficiency virus type 1 long terminal repeat.

Authors:  C Z Song; P M Loewenstein; M Green
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

Review 5.  Structure, regulation and function of NF-kappa B.

Authors:  U Siebenlist; G Franzoso; K Brown
Journal:  Annu Rev Cell Biol       Date:  1994

6.  E1A-associated p300 and CREB-associated CBP belong to a conserved family of coactivators.

Authors:  Z Arany; W R Sellers; D M Livingston; R Eckner
Journal:  Cell       Date:  1994-06-17       Impact factor: 41.582

7.  Activation of cAMP and mitogen responsive genes relies on a common nuclear factor.

Authors:  J Arias; A S Alberts; P Brindle; F X Claret; T Smeal; M Karin; J Feramisco; M Montminy
Journal:  Nature       Date:  1994-07-21       Impact factor: 49.962

8.  The zinc finger region of the adenovirus E1A transactivating domain complexes with the TATA box binding protein.

Authors:  J V Geisberg; W S Lee; A J Berk; R P Ricciardi
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

9.  Subregions of the adenovirus E1A transactivation domain target multiple components of the TFIID complex.

Authors:  J V Geisberg; J L Chen; R P Ricciardi
Journal:  Mol Cell Biol       Date:  1995-11       Impact factor: 4.272

10.  CBP-induced stimulation of c-Fos activity is abrogated by E1A.

Authors:  A J Bannister; T Kouzarides
Journal:  EMBO J       Date:  1995-10-02       Impact factor: 11.598

View more
  8 in total

1.  HIV transcriptional activation by the accessory protein, VPR, is mediated by the p300 co-activator.

Authors:  L K Felzien; C Woffendin; M O Hottiger; R A Subbramanian; E A Cohen; G J Nabel
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

2.  Specificity of cyclin E-Cdk2, TFIIB, and E1A interactions with a common domain of the p300 coactivator.

Authors:  L K Felzien; S Farrell; J C Betts; R Mosavin; G J Nabel
Journal:  Mol Cell Biol       Date:  1999-06       Impact factor: 4.272

3.  Histone acetyltransferases regulate HIV-1 enhancer activity in vitro.

Authors:  P L Sheridan; T P Mayall; E Verdin; K A Jones
Journal:  Genes Dev       Date:  1997-12-15       Impact factor: 11.361

4.  Effect of adenovirus E1A on ICAM-1 promoter activity in human alveolar and bronchial epithelial cells.

Authors:  Y Higashimoto; N Keicho; W M Elliott; J C Hogg; S Hayashi
Journal:  Gene Expr       Date:  1999

5.  Mechanism of action of a distal NF-kappaB-dependent enhancer.

Authors:  Belete Teferedegne; Myesha R Green; Zhu Guo; Jeremy M Boss
Journal:  Mol Cell Biol       Date:  2006-08       Impact factor: 4.272

6.  Role of the E1A Rb-binding domain in repression of the NF-kappa B-dependent defense against tumor necrosis factor-alpha.

Authors:  James L Cook; Thomas A Walker; G Scott Worthen; Jay R Radke
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-15       Impact factor: 11.205

7.  The adenovirus e3 promoter is sensitive to activation signals in human T cells.

Authors:  Jeffrey A Mahr; Jeremy M Boss; Linda R Gooding
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

Review 8.  Latent adenovirus infection in COPD.

Authors:  Shizu Hayashi
Journal:  Chest       Date:  2002-05       Impact factor: 9.410

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.